342 related articles for article (PubMed ID: 20132554)
1. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
4. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
5. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
Meng CF; Zhu XJ; Peng G; Dai DQ
World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
[TBL] [Abstract][Full Text] [Related]
6. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
7. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
8. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of maspin gene expression in human breast cancers.
Domann FE; Rice JC; Hendrix MJ; Futscher BW
Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
[TBL] [Abstract][Full Text] [Related]
11. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
12. Re-expression and epigenetic modification of maspin induced apoptosis in MCF-7 cells mediated by myocardin.
Liao XH; Li YQ; Wang N; Zheng L; Xing WJ; Zhao DW; Yan TB; Wang Y; Liu LY; Sun XG; Hu P; Zhou H; Zhang TC
Cell Signal; 2014 Jun; 26(6):1335-46. PubMed ID: 24607789
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
[TBL] [Abstract][Full Text] [Related]
14. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
15. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of maspin expression in the human placenta.
Dokras A; Coffin J; Field L; Frakes A; Lee H; Madan A; Nelson T; Ryu GY; Yoon JG; Madan A
Mol Hum Reprod; 2006 Oct; 12(10):611-7. PubMed ID: 16936308
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
18. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
[TBL] [Abstract][Full Text] [Related]
19. Expression and regulation of tumor suppressor gene maspin in human bladder cancer.
Sugimoto S; Maass N; Takimoto Y; Sato K; Minei S; Zhang M; Hoshikawa Y; Jünemann KP; Jonat W; Nagasaki K
Cancer Lett; 2004 Jan; 203(2):209-15. PubMed ID: 14732229
[TBL] [Abstract][Full Text] [Related]
20. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.
da Costa Prando E; Cavalli LR; Rainho CA
Epigenetics; 2011 Dec; 6(12):1413-24. PubMed ID: 22139571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]